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Donald Heath will always be remembered for his contribution to our understanding of the pulmonary circulation, high altitude pathology, and the rediscovery of the carotid body. He was fascinated by the concept of the neuroendocrine lung, and played a part in an early study of the clinicopathological behaviour of bronchopulmonary carcinoid tumours.' Twenty two tumours were examined and their histology was reviewed blind by Professor Heath. The surgeon writing the paper therefore had the opinion of two histopathologists and, as he stated, "this method, although unfair to the pathologist, seemed one by which an assessment of the importance of the histology might be made. Its shortcomings were apparent, one being that although the histological appearance was the criterion for admission of a patient to the series, its importance was in part denied in assessing the ultimate outcome". The histological appearances were divided into "regular" with "orderly cell arrangement", and "irregular" with "pleomorphism, unusual arrangement or occasional mitosis".
The problems encountered in histological diagnosis, which remain to some extent today, were illustrated by three cases. They were classified as "irregular", "regular", and "irregular" by one observer and "malignant but not carcinoid", oat-cell carcinoma, and "regular", respectively, by the other. This led the surgeon to question the value of the histological appearance in assessing prognosis in these tumours. This review will focus on studies undertaken mainly after 1969 to address the clinicopathological correlation in bronchopulmonary carcinoid tumours, and methods of predicting their biological behaviour.
features, but nearly 20% of cases are asymptomatic. 5 Endocrine manifestations, including the carcinoid syndrome8 with left sided valvular lesions, are rare with an incidence of 1-7%.9-" This may be because the amount of tumour tissue present is insufficient to produce the mediators responsible for the syndrome, or because the peptides, prostaglandins, kinins, and other mediators produced by these tumours are rapidly inactivated by the lung and liver.'2 The syndrome occurs most commonly in pulmonary carcinoid tumours with metastases.4' These arguments do not allow for tumours draining into the left atrium via the pulmonary veins. Although immunocytochemical examination can demonstrate many peptides and other mediators in these tumours, this technique may be particularly sensitive or the total amount of mediator produced may be too small to cause valvular disease.
Acromegaly,'4 Cushing's syndrome,'5 and insulin production with hypoglycaemia'6 are also rare. The tumour may be part of the multiple endocrine adenomatosis syndrome. Elevated levels of growth hormone releasing hormone may be detected without acromegaly.'7 More recently hypercalcaemia has been described in atypical bronchial carcinoid tumours; it is not known whether this is the result of osteolytic metastases or whether there is some other tumour associated cause.'8
Only 60-77% of tumours are visible through a bronchoscope. They bleed easily and this feature has been cited as a contraindication to biopsy.'9 However, a study describing 33 atic or vascular permeation, mitoses, nuclear pleomorphism, and an undifferentiated growth pattern. 22 An undifferentiated growth pattern may coexist with trabecular, insular, or acinar areas and is defined as one where it is impossible to define one of the other three growth patterns as identified above. The presence oflymph node metastases, while suggesting a well differentiated neuroendocrine carcinoma, should not be taken as evidence that the tumour is behaving in a malignant fashion in all cases. We have seen occasional cases with a typical carcinoid pattern, lymph node metastases, and a long postoperative survival. When larger series are analysed the presence of lymph node metastases is an adverse prognostic factor.
Endobronchial biopsies from well differentiated neuroendocrine carcinomas may be misdiagnosed as small cell carcinoma. This is usually because of sampling error and, when the lung is removed, areas with a definite carcinoid pattern are identified. It is therefore important that as large a biopsy specimen as possible is obtained so that the correct diagnosis can be made. The prognosis for well differentiated neuroendocrine carcinoma is better than for small cell carcinoma.2324 Large cell neuroendocrine carcinoma25 should also be added to this classification.
While atypical carcinoid tumours (well differentiated neuroendocrine carcinoma) and small cell neuroendocrine carcinoma have different histological patterns and prognoses, the concept of neuroendocrine carcinoma is a useful one in identifying the cell of origin.
Histology
Typical carcinoid tumours show many patterns, 
Bone formation in bronchial carcinoid tumours
Between 10%" and 25% of bronchial carcinoma tumours contain bone22 (fig 9) . If peripheral carcinoid tumours are excluded this figure rises to 30%. This ability to produce bone appears to be largely confined to bronchial tumours since it is almost never seen in ileal or appendiceal carcinoid tumours. In some cases bone is present in relation to bronchial cartilage, but in many it is seen in the middle of the tumour. Cartilage may also be found in some tumours and may play a part in bone formation.
The mechanism of bone formation is unknown. Cooney et alj4 believed that it was the result of locally produced calcitonin and found this hormone immunocytochemically in four of seven bone-containing carcinoid tumours. However, medullary carcinoma of the thyroid, a tumour rich in calcitonin, shows calcification but no bone,35 and we have found carcinoid tumours with no bone but with calcitonin immunoreactivity.22 Acid phosphatase and 5-nucleotidase have also been suggested as the cause of the ectopic bone, but a recent case was negative for both these enzymes. '6 We have recently demonstrated IGF-1 (insulin growth factor 1) in bronchial carcinoid tumours. This growth factor is mitogenic for various mesoderm-derived cells in vitro,37 and functions both in an endocrine manner as well as locally within tissues in a paracrine/autocrine mode associated with other growth factors. The main role of IGF-1 is in the growth of young mammals, and its production is regulated by pituitary growth hormone whose growth-promoting activity on skeletal tissues it, in its turn, mediates.'83' Insulin growth factors are unique in that they can stimulate both growth and differentiation. Individual As cytogenetic changes are a recognised feature of many human tumours and may be related to clinical behaviour, it was thought that DNA ploidy may be of independent prognostic value. This hope was not fulfilled and DNA ploidy osin, did not confer any independent prognostic information in bronchial carcinoid tumours. In a study of 53 patients those with DNA diploid tumours tended to survive longer than those with DNA aneuploidy,43 but the difference was ofborderline statistical significance ( fig 11) . It is .; possible that statistical significance for survival between aneuploid and diploid status might be reached in a larger study. Well differentiated neuroendocrine carcinomas showed a greater tendency to be aneuploid than typical carcinoid 9 tumours (table 1). The incidence of DNA aneuploidy in tumours with lymph node metastases X (11/13, 85%) was significantly higher than Kt those without (12/36, 33%; X2= 8-1, p<O002).
Two typical tumours had lymph node metastases and were DNA aneuploid. In a Cox multivariate analysis the most powerful predictor of prognosis was the histological growth pattern. The other variables of independent significance were the presence of involved lymph nodes and the presence of nuclear pleomorphism.
Another flow cytometric study of 47 tendency for immunoreactivity of these tumours to various peptides to be less strongly expressed in atypical than in typical tumours. 47 Well differentiated neuroendocrine carcinoma has been shown in one study to express ACTH more frequently than typical carcinoid tumours. 48 Only nine cases were examined and these results are at variance with ours. A difference in antisera could explain these discrepancies.
The 
